These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15185321)

  • 61. More clues to the relationship between hepatic iron and steatosis: An association with insulin resistance?
    Macdonald GA; Powell LW
    Gastroenterology; 1999 Nov; 117(5):1241-4. PubMed ID: 10535890
    [No Abstract]   [Full Text] [Related]  

  • 62. Primary iron overload and HFE gene mutations in North Indian adults.
    Patil PS; Mohandas KM
    Indian J Gastroenterol; 2012 Jan; 31(1):36-7; author reply 37. PubMed ID: 22362317
    [No Abstract]   [Full Text] [Related]  

  • 63. Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation.
    Duseja A; Das A; Dhiman RK; Chawla YK; Das R; Bhadada S; Sialy R; Thumburu KK; Bhansali A; Kalra N
    World J Gastroenterol; 2007 Jan; 13(4):649-50. PubMed ID: 17278239
    [No Abstract]   [Full Text] [Related]  

  • 64. [Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver].
    Fernández Salazar LI; Aller de la Fuente R; Velayos Jiménez B; González Hernández JM
    Gastroenterol Hepatol; 2005; 28(6):364. PubMed ID: 15989823
    [No Abstract]   [Full Text] [Related]  

  • 65. Effects of iron and HFE mutations on response to therapy in chronic hepatitis C: an ironic interaction?
    Alexander J; Kowdley KV
    Gastroenterology; 2006 Nov; 131(5):1635-8. PubMed ID: 17067603
    [No Abstract]   [Full Text] [Related]  

  • 66. Dysmetabolic iron overload syndrome and its relationship with HFE gene mutations and with liver steatosis.
    Castiella A; Urreta I; Zapata E; de Juan M; Alústiza JM; Emparanza JI;
    Dig Liver Dis; 2020 Jun; 52(6):683-685. PubMed ID: 32359860
    [No Abstract]   [Full Text] [Related]  

  • 67. Non-viral causes of hepatocellular carcinoma.
    Blonski W; Kotlyar DS; Forde KA
    World J Gastroenterol; 2010 Aug; 16(29):3603-15. PubMed ID: 20677332
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of cirrhosis with an elevated ferritin.
    Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):368-70. PubMed ID: 22037432
    [No Abstract]   [Full Text] [Related]  

  • 69. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal.
    Bataller R; North KE; Brenner DA
    Hepatology; 2003 Mar; 37(3):493-503. PubMed ID: 12601343
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hemochromatosis gene mutations in patients with alcoholic cirrhosis.
    Starcevic Cizmarevic N; Stepec S; Ristić S; Milić S; Brajenović-Milić B; Stimac D; Kapović M; Peterlin B
    Clin Genet; 2006 Sep; 70(3):257-9. PubMed ID: 16922731
    [No Abstract]   [Full Text] [Related]  

  • 71. Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload.
    Green L; De Lord C; Clark B; Cadet E; Rochette J; Thein SL
    Br J Haematol; 2011 Aug; 154(3):288. PubMed ID: 21521183
    [No Abstract]   [Full Text] [Related]  

  • 72. Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis.
    Banner BF; Savas L; Zivny J; Tortorelli K; Bonkovsky HL
    Am J Clin Pathol; 2000 Dec; 114(6):860-6. PubMed ID: 11338474
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiple liver lesions of unusual benign etiology mimicking metastatic disease.
    Pais TP; Fernandes S; Fraga J
    Gastroenterology; 2014 Aug; 147(2):e10-1. PubMed ID: 24973686
    [No Abstract]   [Full Text] [Related]  

  • 74. Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload?
    Moirand R; Mendler MH; Guillygomarc'h A; Brissot P; Deugnier Y
    J Hepatol; 2000 Dec; 33(6):1024-6. PubMed ID: 11131442
    [No Abstract]   [Full Text] [Related]  

  • 75. Iron overload and liver fibrosis.
    Arthur MJ
    J Gastroenterol Hepatol; 1996 Dec; 11(12):1124-9. PubMed ID: 9034931
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum iron levels and hepatic iron overload in patients with nonalcoholic steatohepatitis.
    Duseja A; Das R; Das A; Dhiman RK; Chawla YK; Garewal G
    Dig Dis Sci; 2006 Oct; 51(10):1730-1. PubMed ID: 16964548
    [No Abstract]   [Full Text] [Related]  

  • 77. Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?
    Charlton M
    Hepatology; 2008 May; 47(5):1431-3. PubMed ID: 18393323
    [No Abstract]   [Full Text] [Related]  

  • 78. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD.
    Kupčová V; Fedelešová M; Bulas J; Kozmonová P; Turecký L
    Int J Environ Res Public Health; 2019 Sep; 16(19):. PubMed ID: 31554274
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.
    Sirota JC; McFann K; Targher G; Johnson RJ; Chonchol M; Jalal DI
    Metabolism; 2013 Mar; 62(3):392-9. PubMed ID: 23036645
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Hernaez R; Yeung E; Clark JM; Kowdley KV; Brancati FL; Kao WH
    J Hepatol; 2011 Nov; 55(5):1079-85. PubMed ID: 21354231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.